Funded by Alzheimer’s Research UK, Dementia Futures offers a valuable opportunity for researchers to network, share knowledge and present key findings about ongoing dementia research to the general ...

Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative diseases.

the National Institute for Health and Care Excellence (NICE) recommended that lecanemab not be provided on the NHS because it is not currently cost effective. “Dementia is the biggest health and ...

Drugs like Lecanemab, which has been shown to slow down the development of dementia, have recently been approved in the UK (though it ... of Bristol Cabot Institute for the Environment, said.

Who will provide your care and how to contact them, including the professional ... This content has been co-produced by NICE and the Social Care Institute for Excellence (SCIE). It is based on NICE’s ...

SPONSORED Medtech concepts are a dime a dozen in Australia. But to overcome our health care challenges, innovations must be ...

Oral and poster presentations of results from Study 501 evaluating lumateperone 42 mg as an adjunctive therapy to ...

Note to editors The study was conducted at the University of Surrey by researchers funded by the UK Dementia Research Institute's (UK DRI ... is available for interview upon request; please contact ...

A new study has uncovered a startling revelation: rare genetic disorders caused by repetitive DNA sequences may be up to ...

The Future of Dementia in Africa is a Nature Conference, convened by Davos Alzheimer’s Collaborative and the Aga Khan University Brain and Mind Institute. It will take place in Nairobi, Kenya. The ...

A growing body of evidence shows that the impact of lockdown continues to affect every generation – and will do for decades ...